Essentials of Clinical Research

  • Stephen P. Glasser

Table of contents

  1. Front Matter
    Pages i-vi
  2. Stephen P. Glasser
    Pages 33-74
  3. Stephen P. Glasser
    Pages 75-90
  4. Stephen P. Glasser, Elizabeth Delzell, Maribel Salas
    Pages 91-116
  5. Stephen P. Glasser, Carol M. Ashton, Nelda P. Wray
    Pages 117-143
  6. Stephen P. Glasser, William Frishman
    Pages 145-176
  7. Stephen P. Glasser
    Pages 177-192
  8. Stephen P. Glasser, O. Dale Williams
    Pages 193-202
  9. Stephen P. Glasser, Sue Duval
    Pages 203-231
  10. Sadeep Shrestha, Donna K. Arnett
    Pages 233-256
  11. Maribel Salas, Bruno Stricker
    Pages 257-273
  12. Amanda S. Mixon, Lauren Powell, Carlos A. Estrada
    Pages 275-312
  13. Stephen P. Glasser
    Pages 313-326
  14. Stephen P. Glasser, Gary Cutter
    Pages 345-362
  15. Stephen P. Glasser, George Howard
    Pages 373-390
  16. Donna K. Arnett, Stephen P. Glasser
    Pages 391-418
  17. Stephen P. Glasser
    Pages 419-425
  18. Stephen P. Glasser, Edward W. Hook III
    Pages 427-435
  19. Stephen P. Glasser
    Pages 437-447
  20. Back Matter
    Pages 449-461

About this book


In its extensively revised and updated Second Edition, this book provides a solid foundation for readers interested in clinical research. Discussion encompasses genetic, pharmacoepidemiologic and implementation research.

All chapters have been updated with new information and many new tables have been added to elucidate key points. The book now offers discussion on how to handle missing data when analyzing results, and coverage of Adaptive Designs and Effectiveness Designs and new sections on Comparative Effectiveness Research and Pragmatic Trials. Chapter 6 includes new material on Phase 0 Trials, expanded coverage of Futility Trials, a discussion of Medical Device approval, Off Label Drug use and the role of the FDA in regulating advertising. Additional new information includes the role of pill color and shape in association with the placebo effect and an examination of issues surrounding minority recruitment. The final chapter offers a new section on manuscript preparation along with a discussion of various guidelines being adopted by journals: CONSORT, STROBE, PRISMA, MOOSE and others; and coverage of Conflicts of Interest, Authorship, Coercive Citation, and Disclosures in Industry-Related Associations.

Building on the strengths of its predecessor in its comprehensive approach and authoritative advice, the new edition offers more of what has made this book a popular, trusted resource for students and working researchers alike.


clinical research clinical trials metaanalysis new drug development pharmacoepidemiology placebo and nocebo

Editors and affiliations

  • Stephen P. Glasser
    • 1
  1. 1.Division of Preventive MedicineUniversity of Alabama at BirminghamBirminghamUSA

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing Switzerland 2014
  • Publisher Name Springer, Cham
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-3-319-05469-8
  • Online ISBN 978-3-319-05470-4
  • Buy this book on publisher's site